Where

Online

When

December 3, 2020

Time

1:00 pm
&
7:00 pm

Richard Holt, Professor in Diabetes and Endocrinology, Southampton

Join us at either 1pm or 7pm, for an hour, and ask your questions.
This webinar has been developed, organised and funded by Novo Nordisk. For healthcare professionals only. Promotional information on insulin degludec (Tresiba®) will be discussed in this webinar. Click here to view prescribing information for insulin degludec (Tresiba®). Insulin degludec (Tresiba®) is indicated for the treatment of diabetes mellitus in adults, adolescents and children from the age of 1 year.
  • Epidemiology of cognitive function and dementia in people with diabetes


  • Mechanisms linking diabetes and dementia


  • Consequences of co-morbidity


  • Clinical implications

    Date of prep: November 2020 - Job Code: UK20TSM00199

    Days
    Hours
    Minutes
    Seconds